HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study.

AbstractPURPOSE:
Many male survivors of childhood cancer are at risk for azoospermia. Although both the levels of follicle-stimulating hormone (FSH) and inhibin B are correlated with sperm concentration, their ability to predict azoospermia in survivors of childhood cancer remains uncertain.
PATIENTS AND METHODS:
Semen analysis was performed and serum levels of FSH and inhibin B were measured in 275 adult male survivors of childhood cancer who had received gonadotoxic therapy. Receiver operating characteristic (ROC) analysis was performed to determine the optimal inhibin B and FSH values for identifying patients with azoospermia. The patient sample was divided into a learning set and a validation set. Sensitivity, specificity, and positive and negative predictive value were calculated.
RESULTS:
Inhibin B was dichotomized as ≤ 31 ng/L or more than 31 ng/L and FSH was dichotomized as ≤ 11.5 mIU/mL or more than 11.5 mIU/mL based on results of the ROC analysis. Using these values, the specificity of the serum level of inhibin B for identifying azoospermic survivors was 45.0%, and the positive predictive value was 52.1%. The specificity for FSH was 74.1%, and the positive predictive value was 65.1%.
CONCLUSION:
Neither serum inhibin B nor FSH is a suitable surrogate for determination of sperm concentration in a semen sample. Young men and their physicians should be aware of the limitations of these measures for assessment of fertility potential.
AuthorsDaniel M Green, Liang Zhu, Nan Zhang, Charles A Sklar, Raymond W Ke, William H Kutteh, James L Klosky, Sheri L Spunt, Monika L Metzger, Fariba Navid, DeoKumar Srivastava, Leslie L Robison, Melissa M Hudson
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 31 Issue 10 Pg. 1324-8 (Apr 01 2013) ISSN: 1527-7755 [Electronic] United States
PMID23423746 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Follicle Stimulating Hormone, beta Subunit
  • Glycoprotein Hormones, alpha Subunit
  • inhibin B
  • Inhibins
  • Follicle Stimulating Hormone
Topics
  • Adolescent
  • Adult
  • Azoospermia (blood, diagnosis)
  • Child
  • Child, Preschool
  • Cohort Studies
  • Follicle Stimulating Hormone (blood)
  • Follicle Stimulating Hormone, beta Subunit (blood)
  • Glycoprotein Hormones, alpha Subunit (blood)
  • Humans
  • Infant
  • Infant, Newborn
  • Inhibins (blood)
  • Male
  • Middle Aged
  • Neoplasms (blood, diagnosis, therapy)
  • Predictive Value of Tests
  • ROC Curve
  • Semen (cytology)
  • Sperm Count
  • Survivors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: